Bandingkan Harga & Kinerja Ancora Indonesia Resources Tbk. (OKAS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Ancora Indonesia Resources Tbk. dan Organon Pharma Indonesia Tbk.: Ancora Indonesia Resources Tbk. diperdagangkan di Rp116 (kapitalisasi pasar 280,07 M, volume 24 jam 3,46 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Ancora Indonesia Resources Tbk. jauh lebih besar — sekitar 2,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| OKAS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 280,07 M | 104,4 M |
Volume | 3,46 jt | — |
Lot | 34,59 rb | — |
Perputaran | 403,59 jt | — |
Harga Rata-rata | 116,69 | — |
Nilai Transaksi | 403,59 jt | — |
Harga Ekuilibrium Indikatif | 116 | — |
Volume Ekuilibrium Indikatif | 567 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Ancora Indonesia Resources Tbk.
PT Ancora Indonesia Resources Tbk (the Company) was establised on September 15, 2003. Based to the Extraordinary General Meeting of Shareholders,all shareholders approved the change of the Company's name from PT TD Resources Tbk to PT Ancora Indonesia Resources Tbk. This change of the Company's name was effective on December 3, 2008.
Selengkapnya di halaman OKAS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
